T淋巴细胞增殖在实验性变态反应性脑脊髓炎发病中的作用
被引量:1
摘要
目的 探讨T淋巴细胞增殖在实验性变态反应性脑脊髓炎 (EAE)发病中的作用。方法 观察Lewis大鼠主动EAE临床症状和T淋巴细胞增殖。结果 EAE临床发病过程中 ,T淋巴细胞增殖旺盛。结论 EAE时 ,活化的T淋巴细胞可以通过BBB进入CNS ,浸入CNS的淋巴细胞能产生破坏性的细胞因子TNF α及某些酶类 ,推测T淋巴细胞增殖活跃 ,在导致EAE发病过程中起着至关重要的作用。
出处
《卒中与神经疾病》
2002年第2期114-115,共2页
Stroke and Nervous Diseases
参考文献9
-
1[1]Swanborg RH,Swierkosz JE,Saieg RG.Studies on the species-variability of experimental allergic encephalomyelitis in guinea pigs and rats.J Immunol,1974,112:594
-
2[2]Koh CS,Paterson PY.Supression of clinical signs of cell-transferred experimental allergic encephalomyelitis and altered cerebrovascular permeability in Lewis rats treated with a plasminogen activator inhibitor.Cellular Immunol,1987,107:52
-
3[3]Inoue A,Koh CS,Shimada K,et al.Suppression cell-transferred experimental autoimmune encephalomyelitis in defibrinated Lewis ras.J Neuroimmunol,1996,71:131
-
4[4]Muhallab S,Lidman O,Weissert R,et al.Intra-CNS activation by antigen-specific T lymphocytes in experimental autoimmune encephalomyelitis.J Neuroimmunol,2001,113:202
-
5[5]Hilliard B,Wilmen A,Sdiedl C,et al.Roles of TNF-related apoptosis-inducing ligand in exprimental autoimmune encephalomyelitis.J Immunol,2001,166:1314
-
6[6]Gearing AJH,Beckett P,Christodoulou M,et al.Processing of tumour necrosis factor-α precursor by metalloproteinases.Nature,1994,370:555
-
7[7]Gijbels K,Galardy RE,Steinman L.Reversal of autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases.J Clin Invest,1994,94:2177
-
8[8]Hewson AK,Smith T,Leonard JP,et al.Suppression of experimental allergic encephalomyelitis in the Lewis rat by the matrix metalloproteinase inhibitor Ro31-9790.Inflamm Res,1995,44:345
-
9[9]Clements JM,Cossins JA,Wells GMA,et al.Matrix metalloproteinase expression during experimental autoimmune encephalomyelitis and effects of a combined matrix metalloproteinase and tumour necrosis factor-α inhibitor.J Neuroimmunol,1997,74:85
同被引文献10
-
1Van der Aa A, Hellings N, Bernard CC, et al. Functional properties of myelin oligodendrocyte glycoprotein-reaetive T cells in multiple sclerosis patients and controls. J Neuroimmunol, 2003,137(1-2):164-176.
-
2Olesson T. Role of cytokines in multiple sclerosis and experimental allergic encephalomyelitis. Eur J Neuro, 1994,1(1):7-19.
-
3Matejuk A, Dwyer J, Ito A, et al. Effects of cytokine deficiency on chemokine expression in CNS of mice with EAE. J Neurosci Res, 20(12,67(5):680-688.
-
4Merrill J, Benveniste E. Cytokiines in inflammatory brain lesions: helpful and harmful. Trends Neurosci, 1996, 19(8): 165-177.
-
5Davidson TS, Hiekey WF. Antisecretory factor expression is regulated by inflammatory mediators and influences the severity of experimental autoimmune encephalomyelitis. J Lcukoc Biol,2004,76(4): 835-844.
-
6Barcellos LF, Dksenberg LF, Green AJ, et al. Genetic basis for clinical expression in multiple scterosis. J Brain, 2002,125(1):150-158.
-
7Zhang X, Koldzic DN, Izikson L, et al. IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25 + CD4 + regulatory T cells. Int Immunol, 2004, 16(2) :249-256,
-
8Karni A, Koldzic DN, Bharanidharan P, et al. IL-18 is linked to raised IFN gamma in multiple sclerosis and is induced by activated CD4(+) T cells via CD40-CD40 ligand interactions. J Neuroimmunol, 2002,125(1-2): 134-140.
-
9Losy J, Niezagoda A. IL-18 in patients with multiple sclerosis.Acta Neurol Scand 2001,104(3): 171-173.
-
10Nagai T, Devergne O, Mueller TF, et al. Timing of IFN-beta exposure during human dendritic cell maturation and naive Th cell stimulation has contrasting effects on Th1 subset generation: a role for IFN-beta-mediated regulation of IL-12 family cytokines and IL-18 in naive Th cell differentiation. J Immunol,2003,171(10): 5233-5243.
二级引证文献4
-
1李森美,陈荣波,吴丽萍,巫顺秀.多发性硬化患者白介素18的表达与临床相关研究[J].神经疾病与精神卫生,2007,7(6):419-421. 被引量:2
-
2吕洁.IL-18、IL-12与IFN-γ参与多发性硬化的免疫病理过程[J].医学综述,2008,14(18):2724-2726.
-
3吕洁,王军.缓解-复发型多发性硬化患者血清中IL-18、IFN-γ水平的变化[J].基础医学与临床,2008,28(9):992-993. 被引量:1
-
4王军,吕洁,姜友珍.复发-缓解型多发性硬化和化脓性脑膜炎患者血清和脑脊液中IL-18和IFN-γ水平的研究[J].脑与神经疾病杂志,2009,17(5):332-334. 被引量:3
-
1吕佩源,宋春风,高昌星,井上敦.实验性变态反应性脑脊髓炎T淋巴细胞增殖和肿瘤坏死因子-α变化的意义(英文)[J].疑难病杂志,2006,5(3):161-163. 被引量:1
-
2吕佩源,宋春风,高昌星,井上敦.实验性变态反应性脑脊髓炎T淋巴细胞增殖和肿瘤坏死因子-α变化的意义[J].中国神经免疫学和神经病学杂志,2001,8(4):201-203. 被引量:3
-
3焦虹,王维治,王丽华,陈丽霞.FTY720治疗实验性自身免疫性神经炎的研究[J].哈尔滨医科大学学报,2011,45(5):442-444. 被引量:2
-
4张清勇,张国荣,王铁栓,杨俊杰,李世校,乔美丽,张静,张斌.重症肌无力病人胸腺提取液对人淋巴细胞增殖的影响[J].河南医科大学学报,1993,28(4):308-310.
-
5吴以岭,袁国强,周勇,王旭丹.肌炎灵对多发性肌炎动物模型血清抗体及T淋巴细胞增殖的影响[J].中国中医基础医学杂志,2005,11(1):29-31.
-
6沈霞,张作慧,崔桂云,雒东江,王慧.阿伐他汀对实验性变态反应性脑脊髓炎治疗作用的初步研究[J].徐州医学院学报,2005,25(1):32-35. 被引量:1
-
7王炜,南振鸿,管红兵,吕传真.脑梗死髓鞘蛋白反应性IFN-γ的动态检测[J].中国临床神经科学,2000,8(3):199-200.
-
8吕佩源,宋春风,高昌星,井上敦.ONO-4817对实验性变态反应性脑脊髓炎的治疗作用[J].中国药学杂志,2003,38(1):28-31.
-
9高聪,郑建筝,区腾飞,杨洁.阿托伐他汀在实验性变态反应性脑脊髓炎中的作用机制研究[J].实用医学杂志,2008,24(1):20-23. 被引量:3
-
10宋春杰,尹岭,朱克.清开灵有效治疗实验性自身免疫性脑脊髓炎[J].中国神经免疫学和神经病学杂志,2003,10(3):156-158. 被引量:20